CPIX - Cumberland outlines continued momentum with 23% revenue growth and advances ifetroban clinical program August, 06 2025 01:52 AM Cumberland Pharmaceuticals Inc. 2025-08-06 01:52:24 ET More on Cumberland Pharmaceuticals Cumberland Pharmaceuticals Inc. (CPIX) Q2 2025 Earnings Call Transcript Cumberland Pharmaceuticals, Inc. (CPIX) Q1 2025 Earnings Call Transcript Financial information for Cumberland Pharmaceuticals For further details see: Cumberland outlines continued momentum with 23% revenue growth and advances ifetroban clinical program